PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: ruvim.izikson@sanofi.com.\', \'Accelerated Enrollment Solutions, Peoria, IL, USA.\', \'Sanofi Pasteur, Marcy l\'Etoile, France.\', \'Sanofi Pasteur, Lyon, France.\', \'Sanofi Pasteur, Swiftwater, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2213-2600(21)00557-910.1016/S2213-2600(21)00557-9
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 35114141
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35114141>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35114141>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all